5/20/17 Plattsburgh Buprenorphine Waiver Training Registration |
1. Plattsburgh Buprenorphine Waiver Training for Physicians, NPs & PAs
When: Saturday, May 20, 2017, 8:00AM - 1:00PM
The NYSDOH, AIDS Institute is sponsoring a free buprenorphine waiver training for clinical providers. In response to the opioid overdose deaths in New York State, increased access to buprenorphine treatment for opioid overdose disorder is urgently needed. Physicians, Nurse Practitioners and Physician Assistants are welcome and highly encouraged to attend this training.
Under current regulations, clinical providers are required to obtain a ‘waiver’ to prescribe buprenorphine. Physicians can acquire this waiver by attending and completing a standardized and required 8-hour training. This training is offered in a half-and-half format [4 hrs of online training followed up by 4 hrs of in-person training]. Upon completion, providers will meet the requirement of the DATA 2000 to be qualified to prescribe buprenorphine for opioid-dependent patients. NPs and PAs are required to complete an additional 16 hours of online training. Please contact us for further information.
CME CREDITS: The School of Public Health, University at Albany designates this live activity for a maximum of 5.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The School of Public Health, University at Albany is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
CME CREDITS: The School of Public Health, University at Albany designates this live activity for a maximum of 5.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The School of Public Health, University at Albany is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
Trainers:
Bruce Trigg, MD, Consultant, Harm Reduction Coalition, New York, NY
Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY
Where: Champlain Valley Physicians Hospital (CVPH) Medical Center, 75 Beekman St., Auditorium B, Plattsburgh, NY 12901
Where: Champlain Valley Physicians Hospital (CVPH) Medical Center, 75 Beekman St., Auditorium B, Plattsburgh, NY 12901
Directions: https://goo.gl/maps/o3qjT6gffU22
*Light breakfast will be provided*
Questions Call/Email: NYSDOH, AIDS Institute, Office of Drug User Health:
Narelle Ellendon, 212-417-4668, narelle.ellendon@health.ny.gov
Lyla Hunt, 518-473-7428, buprenorphine@health.ny.gov
_______________________________________________________________________________
ACCREDITATION: This activity has been planned and implemented by NYSDOH, AIDS Institute in accordance with the accreditation requirements and policies of the American Academy of Addiction Psychiatry (AAAP) and in partnership with Alliance for Positive Health and the Harm Reduction Coalition.
Funding for this course was made possible (in part) by 1U79TI026556 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
_______________________________________________________________________________
ACCREDITATION: This activity has been planned and implemented by NYSDOH, AIDS Institute in accordance with the accreditation requirements and policies of the American Academy of Addiction Psychiatry (AAAP) and in partnership with Alliance for Positive Health and the Harm Reduction Coalition.
Funding for this course was made possible (in part) by 1U79TI026556 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.